Emylcamate (marketed as Striatran by Merck) is an anxiolytic and muscle relaxant. It was patented in the US in 1961 (US Patent 2972564) and advertised for the treatment of anxiety and tension. It was claimed to be superior to meprobamate which was the market leader at the time. It is no longer prescribed.A study of the drug’s effects in mice was done in 1959.
This page contains content from the copyrighted Wikipedia article "Emylcamate"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
